The Complement-scavenging Capacity of IVIG Products
Spycher, Martin O., PhD, CSL Behring AG, Research and Development, Bern 22, Switzerland, Matozan, Katja, University of Bern, Department of Clinical Research, Bern, Switzerland, Minnig, Kathrin, PhD, CSL Behring AG, QA, Bern 22, Switzerland, Miescher, Sylvia, PhD, CSL Behring AG, Research and Development, Bern 22, Switzerland, Zehnder, Roland, CSL Behring AG, Research and Development, Bern 22, Switzerland, Hoefferer, Liane, PhD, CSL Behring AG, Research and Development, Bern 22, Switzerland, Rieben, Robert, PhD, University of Bern, Department of Clinical Research, Bern, Switzerland
Published in Clinical immunology (Orlando, Fla.) (01.01.2007)
Published in Clinical immunology (Orlando, Fla.) (01.01.2007)
Get full text
Journal Article
CSL112, A NOVEL FORMULATION OF HUMAN APOA-I, RAPIDLY ENHANCES CHOLESTEROL EFFLUX CAPACITY OF PLASMA FOLLOWING INFUSION
Easton, Rachael, Diditchenko, Svetlana, Spycher, Martin, Waelchli, Marcel, Imboden, Martin, Schenk, Sabrina, Pragst, Ingo, Wright, Samuel D, AG, CSL Behring
Published in Journal of the American College of Cardiology (27.03.2012)
Published in Journal of the American College of Cardiology (27.03.2012)
Get full text
Journal Article
CSL112, A NOVEL FORMULATION OF HUMAN APOA-I, RAPIDLY ACTIVATES LECITHIN-CHOLESTEROL ACYLTRANSFERASE UPON INFUSION INTO RABBITS AND MONKEYS
Easton, Rachael, Diditchenko, Svetlana, Spycher, Martin, Edler, Monika, Bolli, Reinhard, Bossart, Olivia, Stadler, Dominik, Pragst, Ingo, Haynes, Jill, Wright, Samuel D, AG, CSL Behring
Published in Journal of the American College of Cardiology (27.03.2012)
Published in Journal of the American College of Cardiology (27.03.2012)
Get full text
Journal Article